COVID-19 associated invasive mycoses

COVID-19 associated invasive mycoses Full article

Journal

Immunopathology, Allergology, Infectology
ISSN: 2412-320X

Output data

Year: 2021, Volume: 2021, Number: 4, Pages: 49-53 Pages count : 5 DOI: 10.14427/jipai.2021.4.49

Authors

Kutsevalova O. ¹ , Antonets A. ^2,3,4 , Krylov V. ³ , Nifantiev N. ³ , Miroshnichenko D. ⁵ , Mikutin A. ⁵

Affiliations

1	National Medical Research Center of Oncology, Rostov-on-Don, Russia
2	Don State Technical University, Rostov-on-Don, Russia
3	N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow, Russia
4	Rostov State Medical University, Rostov-on-Don, Russia
5	Rostov Regional Clinical Hospital, Rostov-on-Don, Russia

The COVID-19 pandemic has revealed the new forms of invasive fungal infections. Without timely diagnosis and treatment, mortality reaches 100%. We analyzed 31 observed cases of invasive mucormycosis and aspergillosis in patients with COVID-19 to identify risk factors, the time sequence of the onset of clinical symptoms, and diagnostic features. Major predisposing factors were diabetes mellitus, immunosuppressive therapy, and oncological diseases.

Kutsevalova O. , Antonets A. , Krylov V. , Nifantiev N. , Miroshnichenko D. , Mikutin A.
COVID-19 associated invasive mycoses
Immunopathology, Allergology, Infectology. 2021. V.2021. N4. P.49-53. DOI: 10.14427/jipai.2021.4.49 OpenAlex

≡ OpenAlex:

W4293751568